F13.920 Sedative, hypnotic or anxiolytic use, unspecified with intoxication, uncomplicated

Name of the Condition

• Sedative, hypnotic or anxiolytic use, unspecified with intoxication, uncomplicated

Summary

This condition involves the use of sedative, hypnotic, or anxiolytic substances resulting in intoxication without associated complications. These medications are commonly prescribed for anxiety, insomnia, or sedation but may be used in ways that lead to acute intoxication. The unspecified nature indicates insufficient detail to classify the pattern of use further, and the uncomplicated designation means no additional medical or psychiatric issues are present.

Causes

The condition arises from the use of sedative, hypnotic, or anxiolytic drugs, such as benzodiazepines or barbiturates. Intoxication occurs when these substances are taken in amounts sufficient to produce clinically significant behavioral or psychological changes, such as impaired judgment, drowsiness, or disinhibition. Use may be prescribed or non-medical, and the unspecified nature indicates insufficient detail to classify the pattern of use further.

Risk Factors

• Prolonged or excessive use of these medications
• High dosages or rapid administration
• History of substance use disorders
• Underlying mental health conditions (e.g., anxiety, depression)
• Recreational or non-medical use
• Concurrent use with other substances (e.g., alcohol)

Symptoms

• Impaired coordination or motor skills
• Slurred speech
• Drowsiness or sedation
• Impaired judgment or decision-making
• Mood changes (e.g., irritability or euphoria)
• Nausea or vomiting
• Respiratory depression (in severe cases)

Diagnosis

Diagnosis is based on clinical evaluation of substance use history and assessment of acute intoxication symptoms. The unspecified nature indicates that criteria for a more specific disorder (e.g., abuse, dependence) are not met or documented, and the uncomplicated designation confirms no additional complications. Laboratory tests may be used to confirm substance presence but are not required for diagnosis.

Treatment Options

• Monitoring for respiratory depression or other acute symptoms
• Supportive care to manage symptoms (e.g., airway protection)
• Discontinuation of the substance if safe and appropriate
• Behavioral counseling to address use patterns
• Referral to addiction services if misuse is suspected

Prognosis and Follow-Up

With appropriate management, acute intoxication symptoms typically resolve as the substance is metabolized. Follow-up may include monitoring for recurrence, assessing for underlying substance use disorders, and providing education on safe medication use. Long-term prognosis depends on addressing any contributing factors, such as misuse or mental health conditions.

Complications

• Respiratory depression or failure
• Accidental injury due to impaired coordination
• Worsening of underlying mental health conditions
• Increased risk of overdose with repeated use
• Potential for dependence with prolonged use

Lifestyle & Prevention

• Use medications only as prescribed and avoid exceeding recommended dosages
• Avoid mixing with alcohol or other sedatives
• Store medications securely to prevent non-medical use
• Seek alternative treatments for anxiety or insomnia (e.g., therapy) when possible
• Educate family members on signs of intoxication and when to seek help

When to Seek Professional Help

• If symptoms of intoxication are severe (e.g., difficulty breathing, loss of consciousness)
• If there is concern for overdose or misuse
• If intoxication occurs frequently or interferes with daily functioning
• If withdrawal symptoms develop after discontinuation

Tips for Medical Coders

Document the presence of acute intoxication symptoms and confirm the absence of complications to support the "uncomplicated" designation. Ensure the unspecified nature of the use is reflected in the clinical record, as this code is appropriate when details about the pattern of use (e.g., abuse, dependence) are not documented. Verify that the substance involved is classified as a sedative, hypnotic, or anxiolytic per ICD-10-CM guidelines.